CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
Conditions: Hematologic Diseases; Hematologic Malignancy; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia Interventions: Device: CliniMACS; Procedure: Bone Marrow Transplant; Drug: Hyperfractionated Total Body Irradiation; Drug: Thiotepa; Drug: Cyclophosphamide; Drug: Busulfan; Drug: Melphalan; Drug: Fludarabine Sponsor: Baptist Health South Florida Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials